Discovering Glut1 Deficiency Syndrome
In recognition of the first International Glut1 Awareness Day, guest blogger Trudy Morgan from Glut1 Deficiency UK talks about her experiences.
David Atkins welcomes the Government's Life Sciences Sector Vision
A press release from the UK Bio Industry Association (BIA) welcomes the Government's new Life Sciences Sector Vision and quotes Congenica CEO David Atkins
Diagnosing CALFAN syndrome after years of uncertainty
How clinicians used Congenica to diagnose an exceptionally rare condition, providing a diagnosis for a child's medical issues after years of investigation.
Rapid diagnosis of Long QT syndrome protects family from major health risk
Congenica supports the rapid diagnosis of Long QT syndrome and enables consideration of potentially life-saving interventions for baby and mother.
Clinical OMICs interview with David Atkins CEO Congenica
Clinical OMICs features an interview with Congenica CEO David Atkins who talks about the genomic medicine landscape and Congenica's plans for the future.
Raising awareness of Dravet Syndrome
Galia Wilson and Claire Eldred have provided us with today's article in recognition of International Dravet Syndrome Awareness day, Wednesday 23rd June.
Genomics in the Clinic & the Promise of Precision Medicine
At PMLS Precision Medicine and Rare Disease event, Congenica took part in a panel entitled 'Genomics in the Clinic and the Promise of Precision Medicine'.
Our story of Norrie Disease
We welcome guest blogger Carla Golledge, who shares her story about son Cameron who was born with Norrie disease.
Congenica funded to reduce fatal drug interactions by mapping genes
New software to reduce the number of adverse drug reactions is being developed thanks to a joint investment of £2 million provided by UKRI and L& G.
The challenges and opportunities for growth during a global pandemic
Congenica's Chairman Andy Richards and CEO David Atkins join leaders from biotech / pharma sector to discuss the impact of pandemic in the last 18 months.
Enhanced whole exome analysis enables Veritas Intercontinental to solve more cases
Veritas Genetics partnered with Congenica to improve diagnostic yield & increase the efficiency, throughput and speed of analysis in diagnostic laboratory
Genomic sequencing in a prenatal setting - posters presented at ISPD
Two members of Congenica’s Clinical Interpretation Services team presented posters at the International Conference on Prenatal Diagnosis and Therapy (ISPD)